Proactive Investors - Run By Investors For Investors

CannPal Animal Therapeutics granted medical cannabis permit

The company listed on the ASX in October 2017 after raising $6M.
a dog sitting in a garden
Clinical trials planned for Q1 CY18.

CannPal Animal Therapeutics Ltd (ASX:CP1) has been granted an authorisation to possess and supply cannabis for scientific research by the New South Wales Ministry of Health.

The authorisation has been issued under the provisions of the Drug Misuse and Trafficking Act 1985.

Importantly, the permit allows CannPal to apply for permits to import cannabis for the clinical trials planned for Q1 CY18.

CannPal is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals.

The company listed on the ASX in October 2017 after raising $6 million at an issue price of $0.20 per share.

CannPal has been working closely with Invetus, Australasia’s largest veterinary research organisation, to facilitate the importation of cannabis for scientific research in companion animals.

CannPal’s agreement with Invetus allows the company to store and research its prohibited substances at a secure purpose-built animal health research facility.

The cannabis oils being imported are for the company’s pharmacokinetic and safety studies scheduled for Q1 CY18.

The University of Queensland will be providing bioanalytical services for the studies with the results anticipated in Q2 CY18.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CP1 profile View Profile

CannPal Animal Therapeutics Ltd Timeline

Related Articles

Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
cannabis plant
December 15 2018
The Vancouver-based cannabis group services medical and recreational cannabis markets in Canada and internationally
May 13 2019
1933 Industries is progressing with plans to launch one of Nevada's largest hemp extraction facilities, amidst a flurry of other activity

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use